Search clinical trials for: PrecivityAD2 - Early Testing

Total 7011 results

C2N Diagnostics
Alzheimer's Association

Withdrawn

Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease (ADELAIDE)

Alzheimers Disease
Indiana University
Regenstrief Institute, Inc.; Davos Alzheimer's Collaborative

Completed

DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease (DIGITAL)

Mild Cognitive Impairment

United States
C2N Diagnostics

Active, not recruiting

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey (QUIP II)

Cognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Memory Impairment

United States
VA Office of Research and Development

Withdrawn

An Upper Extremity Exoskeleton to Target Unwanted Joint Synergies During Repetitive Training in Stroke Survivors

Acute Stroke

United States
C2N Diagnostics

Completed

Quality Improvement PrecivityAD Clinician Survey (QUIP I) (QUIP I)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe